Castrate resistant prostate cancer
Clinical trials for Castrate resistant prostate cancer explained in plain language.
Never miss a new study
Get alerted when new Castrate resistant prostate cancer trials appear
Sign up with your email to follow new studies for Castrate resistant prostate cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New radioactive drug takes aim at Hard-to-Treat prostate cancer
Disease control By invitation onlyThis study tests a new radioactive drug, 177Lu-HTK03170, designed to seek out and destroy prostate cancer cells that have spread. It is for men with metastatic castration-resistant prostate cancer whose disease has worsened after other treatments. The trial will first find a safe…
Matched conditions: CASTRATE RESISTANT PROSTATE CANCER
Phase 1/2 • Sponsor: British Columbia Cancer Agency • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Prostate cancer study pulled before it began
Knowledge-focused CancelledThis study was designed to see if a person's race or ethnicity changes how well a combination of drugs (niraparib, abiraterone acetate, and prednisone) works for a specific type of advanced prostate cancer. It planned to compare Black or Hispanic participants with White or Native…
Matched conditions: CASTRATE RESISTANT PROSTATE CANCER
Phase 2 • Sponsor: Latin American Cooperative Oncology Group • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC